Geneva’s Biolux Technology secures CHF 4 million to advance orthodontic innovation

Biolux Technology, a Geneva-based pioneer in light-accelerated orthodontics, has raised CHF 4 million in seed funding to revolutionize orthodontic care with cutting-edge digital solutions.

Biolux Technology, a Geneva-based innovator in light-accelerated orthodontics, has secured CHF 4 million in seed funding. The financing round was led by redalpine, a prominent European venture capital firm, and Revere Partners, the first venture fund dedicated to oral health. The funds will accelerate the development of Biolux’s flagship product, OrthoPulse®, and enable the launch of a smart digital platform offering real-time treatment monitoring and optimization for orthodontists and patients.

OrthoPulse® employs patented near-infrared light therapy to safely accelerate tooth movement, reducing treatment times by up to 50%. With a low failure rate and enhanced reliability, the device addresses a critical challenge in orthodontics—lengthy treatments that often result in decreased patient compliance and higher costs. The new digital platform will further streamline the orthodontic process, offering unparalleled predictability and convenience.

In addition to securing funding, Biolux has appointed Raphael Pascaud as Chairman of the Board. Pascaud, a seasoned leader in the dental industry with experience at companies like DentalMonitoring and Align Technology, will guide Biolux’s strategic growth and innovation efforts.

Making treatments faster, more effective, and more patient-friendly

“This investment and the launch of our digital platform mark pivotal milestones in our mission to revolutionize orthodontics,” said Marcel Pordes, CEO of Biolux Technology. “We are committed to providing faster, more efficient solutions that empower orthodontists and enhance patient care.”

Daniel Dillinger, Principal at redalpine, praised the team: “Biolux is already transforming orthodontics with its FDA-cleared, commercially successful OrthoPulse®. We are excited to support their next phase of growth, particularly their expansion in the U.S. market.”

The orthodontic market, valued at USD 9 billion in 2023, is expected to grow at an annual rate of 15%, reaching USD 21 billion by 2030.